Ticker Hub
ANRO — AI Analysis & Sentiment
4 recent AI-generated analyses for ANRO. Sentiment and confidence insights updated continuously.
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
Alto Neuroscience's appointment of Andrew Miller, a seasoned biopharma executive, significantly bolsters its leadership. This move enhances the com...
May 28, 2026Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
Alto Neuroscience extended its cash runway to 2029 after a $120M PIPE, securing funding for its lead ALTO-207 program through a potential NDA submi...
May 13, 2026Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Alto Neuroscience's initiation of its Phase 2b trial for ALTO-207 is a significant milestone, progressing its lead drug candidate towards potential...
Apr 21, 2026Alto Neuroscience Announces $120 Million Private Placement Financing
Alto Neuroscience's successful $120 million private placement provides crucial funding for its lead drug candidate, ALTO-207, through Phase 3 trial...
Mar 17, 2026